New England Professional Planning Group Inc. Moderna, Inc. Transaction History

New England Professional Planning Group Inc.

  • $192 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021
SELL
$221.9 - $484.47 $142,237 - $310,545
-641 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$129.91 - $234.98 $83,272 - $150,622
641 New
641 $247,000

Others Institutions Holding MRNA

# of Institutions
1,039
Shares Held
245M
Call Options Held
12.1M
Put Options Held
9.36M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track New England Professional Planning Group Inc. Portfolio

Follow New England Professional Planning Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Professional Planning Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Professional Planning Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email